CrizotinibDevelopment of crizotinib resistance: case report.

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1820卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82933-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：113 / 113

相关论文

共 50 条

[31] CrizotinibAcquired resistance to crizotinib: case report
Reactions Weekly, 2017, 1675 (1) : 84 - 84
[32] Ceritinib/crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2018, 1702 (1) : 73 - 73
[33] Alectinib/crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2020, 1798 (1) : 22 - 22
[34] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2017, 1633 (1) : 231 - 231
[35] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2019, 1754 (1) : 120 - 120
[36] CrizotinibALK mutations with acquired resistance to crizotinib: case report
Reactions Weekly, 2015, 1551 (1) : 89 - 89
[37] Crizotinib/selpercatinibDrug resistance and lack of response: case report
Reactions Weekly, 2022, 1918 (1) : 165 - 165
[38] Alectinib/crizotinib/lorlatinibAcquired drug resistance: case report
Reactions Weekly, 2024, 2026 (1) : 24 - 24
[39] Afatinib/crizotinib/erlotinibAcquired EGFR resistance: case report
Reactions Weekly, 2016, 1603 (1) : 15 - 15
[40] Brigatinib/crizotinib/lorlatinibAcquired drug resistance: case report
Reactions Weekly, 2023, 1963 (1) : 135 - 135

← 1 2 3 4 5 →